These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18765834)

  • 1. Bevacizumab sterility in multiple doses from a single-use vial.
    Ornek K; Karahan ZC; Ergin A; Tekeli A; Tekeli O
    Ann Pharmacother; 2008 Oct; 42(10):1425-8. PubMed ID: 18765834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months.
    Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calfactant sterility in multiple doses from single-use vials.
    Reiter PD; Sims C; Harmes L; Paisley J; Rosenberg AA; Valuck RJ
    Ann Pharmacother; 2003 Sep; 37(9):1219-23. PubMed ID: 12921502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple withdrawals from single-use vials: a study on sterility.
    Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
    Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab.
    Das T; Volety S; Ahsan SM; Thakur AK; Sharma S; Padhi TR; Basu S; Rao ChM
    Clin Exp Ophthalmol; 2015 Jul; 43(5):466-73. PubMed ID: 25545882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.
    Bakri SJ; Snyder MR; Pulido JS; McCannel CA; Weiss WT; Singh RJ
    Retina; 2006; 26(5):519-22. PubMed ID: 16770257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation.
    Alam M; Yoo SS; Wrone DA; White LE; Kim JY
    J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on the contamination of injection bevacizumab on storage of multidose vials.
    Saoji K; Trehan H; Narayanan R; Verma L
    Indian J Ophthalmol; 2018 Feb; 66(2):252-255. PubMed ID: 29380769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of Bevacizumab Divided in Multiple Doses for Intravitreal Injection.
    Phasukkijwatana N; Tanterdtham J; Lertpongparkpoom D
    J Med Assoc Thai; 2015 Aug; 98(8):798-803. PubMed ID: 26437538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of compounded bevacizumab prepared for intravitreal injection.
    Yannuzzi NA; Klufas MA; Quach L; Beatty LM; Kaminsky SM; Crystal RG; D'Amico DJ; Kiss S
    JAMA Ophthalmol; 2015 Jan; 133(1):32-9. PubMed ID: 25233052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterility and concentration of liposomal bupivacaine single-use vial when used in a multiple-dose manner.
    Carlson AR; Nixon E; Jacob ME; Messenger KM
    Vet Surg; 2020 May; 49(4):772-777. PubMed ID: 31943286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial integrity of preservative-free alfaxalone in a multiple-use system for two storage conditions and three handling techniques.
    Whitehead MC; Vanetten CL; Jacob ME; Harrison TM
    Am J Vet Res; 2018 Jul; 79(7):704-710. PubMed ID: 29943636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification, microbial contamination, physico-chemical stability of repackaged bevacizumab stored under different conditions.
    Signorello L; Pucciarelli S; Bonacucina G; Polzonetti V; Cespi M; Perinelli DR; Palmieri GF; Pettinari R; Pettinari C; Fiorentini G; Vincenzetti S
    Curr Pharm Biotechnol; 2014; 15(2):113-9. PubMed ID: 24953231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling.
    Liu L; Ammar DA; Ross LA; Mandava N; Kahook MY; Carpenter JF
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1023-34. PubMed ID: 21051703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of bacterial contamination in 50% dextrose vials in varying storage conditions after multiple punctures.
    Marshall KA; Brooks AC; Hammac GK; Thomovsky EJ; Johnson PA
    J Small Anim Pract; 2018 Dec; 59(12):758-762. PubMed ID: 29972244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
    Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
    Woo SJ; Han JM; Ahn J; Heo JW; Yu HG; Chung H; Song J; Park KU; Park KH
    Retina; 2012 Apr; 32(4):667-71. PubMed ID: 22307220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.